ASKA pharmaceutical Co., Ltd.【JP:E00929】Balance sheet

Market cap

P/E ratio

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03
Cash and cash equivalents	-	6,724	5,462	14,761	10,221	10,982	7,294
Marketable securities, current	-	2,850	-	500	1,125	-	-
Accounts receivable, net	-	8,483	8,566	9,485	10,400	11,022	13,792
Inventories	-	6,768	7,777	6,472	6,792	8,661	9,087
Total current assets	-	32,190	26,878	37,059	35,792	37,829	37,326
Property, plant and equipment, net	-	13,103	13,801	12,829	12,091	13,573	13,539
Marketable securities, non-current	-	9,244	8,985	8,714	11,747	11,052	9,794
Total non-current assets	-	26,741	30,599	29,067	30,442	44,365	42,913
Total assets	-	58,933	57,478	66,126	66,235	82,194	80,239
Accounts payable	-	6,856	3,784	5,309	5,218	4,094	3,239
Short-term debt	-	750	1,650	450	450	450	450
Long-term debt, current	-	58	808	750	750	3,048	2,298
Total current liabilities	-	14,874	10,992	16,253	14,214	18,002	17,127
Long-term debt, non-current	-	558	3,250	2,500	1,750	12,970	13,671
Total non-current liabilities	-	7,481	10,524	10,361	9,460	20,735	21,537
Total liabilities	-	22,355	21,517	26,615	23,675	38,738	38,665
Common stock and paid-in capital	-	2,042	2,048	2,048	2,048	2,110	2,125
Retained earnings	-	34,447	34,759	37,312	39,280	40,630	39,560
Stockholders' equity	33,941	36,577	35,961	39,511	42,559	43,456	41,573